NVS fund manager activity
Novartis AG · NYSE. Reported by 17 tracked fund managers in their 13F filings, Q2 2013 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Sarah Ketterer - Causeway Capital Management | Added | 1,501 | $235,168 | 0.00% | Aug 13, 2026 |
| Dodge & Cox Funds | Trimmed | 759,373 | $119,008,937 | 0.06% | Aug 13, 2026 |
| Ken Fisher - Fisher Asset Management | Added | 15,523,378 | $2,432,824,035 | 0.72% | Aug 4, 2026 |
| Jeremy Grantham - GMO | Trimmed | 245,957 | $38,546,381 | 0.09% | Aug 13, 2026 |
| Joel Greenblatt - Gotham Asset Management | No change | 2,683 | $420,480 | 0.00% | Aug 14, 2026 |
| Kahn Brothers Group | Trimmed | 13,186 | $2,066,509 | 0.33% | Aug 17, 2026 |
| Lee Ainslie - Maverick Capital | Added | 27,789 | $4,355,092 | 0.04% | Aug 14, 2026 |
| Tweedy Browne | Trimmed | 71,125 | $11,146,710 | 0.84% | Aug 7, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Sarah Ketterer - Causeway Capital Management | Trimmed | 1,487 | $227,167 | 0.00% | May 14, 2026 |
| Dodge & Cox Funds | Trimmed | 6,967,383 | $1,064,267,753 | 0.58% | May 14, 2026 |
| Ken Fisher - Fisher Asset Management | Added | 13,885,749 | $2,121,048,400 | 0.72% | May 5, 2026 |
| Jeremy Grantham - GMO | Trimmed | 275,637 | $42,103,552 | 0.11% | May 14, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 2,683 | $409,828 | 0.00% | May 15, 2026 |
| Kahn Brothers Group | Trimmed | 13,386 | $2,044,711 | 0.36% | May 8, 2026 |
| Mairs & Power Funds | Sold out | — | — | 0.00% | May 14, 2026 |
| Lee Ainslie - Maverick Capital | Added | 15,247 | $2,328,979 | 0.03% | May 15, 2026 |
| Tweedy Browne | Trimmed | 71,305 | $10,891,839 | 0.87% | May 6, 2026 |
Older quarters